Ventilatory Function, Height, and Mortality Among Lifelong Non-smokers

Overview

Journal J Epidemiol Community Health

Specialty Health Services

Date 1992 Feb 1

PMID 1573363

Citations 27

Authors

D P Strachan

Affiliations

Soon will be listed here.

Abstract

Study Objective: The aims were to determine the relationship between spirometric indices and mortality among lifelong non-smokers, and to investigate whether the association of short stature with increased risk of death is explained by reduced levels of ventilatory function in shorter men.

Design: The study was a nested (within cohort) case-control analysis of an 18 year prospective study of mortality.

Subjects: Participants were 3452 male civil servants aged 40-64 years at entry who denied ever having smoked tobacco.

Measurements And Main Results: 408 men who died were matched to 2874 controls of the same age and height. Reduced one second forced expiratory volume (FEV1) was associated with mortality from non-respiratory causes (rate ratio per litre decrease = 1.44, 95% confidence interval 1.196-1.73). The ratio of FEV1 to forced vital capacity was a weak predictor of mortality. Among 397 case-control sets matched for age and FEV1, mortality was unrelated to height. Comparing mortality differentials across age adjusted tertiles of each risk factor, height adjusted FEV1 was a stronger predictor of death than height, body mass index, or plasma cholesterol. FEV1 adjusted for age but not for height was almost as strong a predictor as systolic blood pressure.

Conclusions: The determinants of ventilatory function in lifelong non-smokers may include causes of premature death. FEV1 may be a more sensitive indicator than height of early life influences upon mortality.

Citing Articles

Associations between vitamin A and K intake and lung function in the general US population: evidence from NHANES 2007-2012.

Chen Y, Hung M Front Nutr. 2024; 11:1417489.

PMID: 39371942 PMC: 11451413. DOI: 10.3389/fnut.2024.1417489.

Genetic loci for lung function in Japanese adults with adjustment for exhaled nitric oxide levels as airway inflammation indicator.

Yamada M, Motoike I, Kojima K, Fuse N, Hozawa A, Kuriyama S Commun Biol. 2021; 4(1):1288.

PMID: 34782693 PMC: 8593164. DOI: 10.1038/s42003-021-02813-8.

Genetic underpinnings of lung function and COPD.

Ranjan A, Singh A, Walia G, Sachdeva M, Gupta V J Genet. 2019; 98.

PMID: 31544798

Socioeconomic status and pulmonary function, transition from childhood to adulthood: cross-sectional results from the polish part of the HAPIEE study.

Polak M, Szafraniec K, Kozela M, Wolfshaut-Wolak R, Bobak M, Pajak A BMJ Open. 2019; 9(1):e022638.

PMID: 30782683 PMC: 6340009. DOI: 10.1136/bmjopen-2018-022638.

Adult height and all-cause and cause-specific mortality in the Japan Public Health Center-based Prospective Study (JPHC).

Ihira H, Sawada N, Iwasaki M, Yamaji T, Goto A, Noda M PLoS One. 2018; 13(5):e0197164.

PMID: 29758048 PMC: 5951564. DOI: 10.1371/journal.pone.0197164.

References

Blackburn H, Taylor H, PARLIN R, Kihlberg J, Keys A . PHYSICAL ACTIVITY OF OCCUPATION AND CIGARETTE SMOKING: RELATIONSHIP TO VENTILATORY FUNCTION AND RESPIRATORY SYMPTOMS. Arch Environ Health. 1965; 10:312-22. DOI: 10.1080/00039896.1965.10664002. View

Reid D, BRETT G, Hamilton P, Jarrett R, Keen H, Rose G . Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet. 1974; 1(7856):469-73. DOI: 10.1016/s0140-6736(74)92783-4. View

Barker D, Osmond C, Law C . The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health. 1989; 43(3):237-40. PMC: 1052843. DOI: 10.1136/jech.43.3.237. View

Ashley F, Kannel W, Sorlie P, Masson R . Pulmonary function: relation to aging, cigarette habit, and mortality. Ann Intern Med. 1975; 82(6):739-45. DOI: 10.7326/0003-4819-82-6-739. View

Friedman G, Klatsky A, SIEGELAUB A . Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1976; 294(20):1071-5. DOI: 10.1056/NEJM197605132942001. View

Higgins M, Keller J . Predictors of mortality in the adult population of Tecumseh. Arch Environ Health. 1970; 21(3):418-24. DOI: 10.1080/00039896.1970.10667260. View

Kannel W . Habitual level of physical activity and risk of coronary heart disease: the Framingham study. Can Med Assoc J. 1967; 96(12):811-2. PMC: 1936138. View

Walker M, Shaper A, Phillips A, Cook D . Short stature, lung function and risk of a heart attack. Int J Epidemiol. 1989; 18(3):602-6. DOI: 10.1093/ije/18.3.602. View

Blair S, Kohl 3rd H, Paffenbarger Jr R, Clark D, COOPER K, Gibbons L . Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989; 262(17):2395-401. DOI: 10.1001/jama.262.17.2395. View

10.

Blair S, Kannel W, Kohl H, Goodyear N, Wilson P . Surrogate measures of physical activity and physical fitness. Evidence for sedentary traits of resting tachycardia, obesity, and low vital capacity. Am J Epidemiol. 1989; 129(6):1145-56. DOI: 10.1093/oxfordjournals.aje.a115236. View

11.

Hawthorne V, Rose G, Shipley M, Gillis C, Hole D, Carmen W . Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol. 1989; 18(1):84-8. DOI: 10.1093/ije/18.1.84. View

12.

Marcus E, Curb J, MacLean C, Reed D, Yano K . Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol. 1989; 129(1):97-104. DOI: 10.1093/oxfordjournals.aje.a115128. View

13.

Anderson H, Vallance P, Bland J, Nohl F, Ebrahim S . Prospective study of mortality associated with chronic lung disease and smoking in Papua New Guinea. Int J Epidemiol. 1988; 17(1):56-61. DOI: 10.1093/ije/17.1.56. View

14.

Farchi G, Menotti A, Conti S . Coronary risk factors and survival probability from coronary and other causes of death. Am J Epidemiol. 1987; 126(3):400-8. DOI: 10.1093/oxfordjournals.aje.a114671. View

15.

Persson C, Bengtsson C, Lapidus L, Rybo E, Thiringer G, Wedel H . Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol. 1986; 124(6):942-8. DOI: 10.1093/oxfordjournals.aje.a114483. View

16.

Annesi I, Kauffmann F . Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis. 1986; 134(4):688-93. DOI: 10.1164/arrd.1986.134.4.688. View

17.

Krzyzanowski M, Wysocki M . The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study. Int J Epidemiol. 1986; 15(1):56-64. DOI: 10.1093/ije/15.1.56. View

18.

Paffenbarger Jr R, HYDE R, Wing A, Hsieh C . Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986; 314(10):605-13. DOI: 10.1056/NEJM198603063141003. View

19.

Beaty T, Newill C, Cohen B, Tockman M, BRYANT S, Spurgeon H . Effects of pulmonary function on mortality. J Chronic Dis. 1985; 38(8):703-10. DOI: 10.1016/0021-9681(85)90024-4. View

20.

Peto R, Speizer F, Cochrane A, Moore F, Fletcher C, TINKER C . The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983; 128(3):491-500. DOI: 10.1164/arrd.1983.128.3.491. View